# Monro, Inc.: financial statements, quarterly

MNRO · Nasdaq · CIK 876427 · [Other](/sectors/other.md) · fiscal year ends Mar 27

Pages: [Overview](/companies/mnro.md) · [Financials](/companies/mnro/financials.md) · [Filings](/companies/mnro/filings.md) · [Insiders](/companies/mnro/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mnro/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-12-23) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) | Q2 FY2027 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [318](/filings/0001562762-25-000015.md) | [310 d](/filings/0000876427-26-000007.md) | [293](/filings/0001562762-25-000184.md) | [301](/filings/0000876427-25-000005.md) | [306](/filings/0000876427-26-000004.md) | [295 d](/filings/0000876427-26-000007.md) | [301](/filings/0000876427-26-000010.md) | [289](/filings/0000876427-26-000012.md) | [293](/filings/0000876427-26-000004.md) | [274 d](/filings/0000876427-26-000007.md) | [287](/filings/0000876427-26-000010.md) | [284](/filings/0000876427-26-000012.md) |
| Gross profit | $m | [113](/filings/0001562762-25-000015.md) | [110 d](/filings/0000876427-26-000007.md) | [109](/filings/0001562762-25-000184.md) | [106](/filings/0000876427-25-000005.md) | [105](/filings/0000876427-26-000004.md) | [97.3 d](/filings/0000876427-26-000007.md) | [107](/filings/0000876427-26-000010.md) | [103](/filings/0000876427-26-000012.md) | [102](/filings/0000876427-26-000004.md) | [92.9 d](/filings/0000876427-26-000007.md) | [100](/filings/0000876427-26-000010.md) | [99.9](/filings/0000876427-26-000012.md) |
| Operating income | $m | [21.4](/filings/0001562762-25-000015.md) | [10.3 d](/filings/0000876427-26-000007.md) | [13.2](/filings/0001562762-25-000184.md) | [13.2](/filings/0000876427-25-000005.md) | [10.0](/filings/0000876427-26-000004.md) | [(23.8) d](/filings/0000876427-26-000007.md) | [(6.1)](/filings/0000876427-26-000010.md) | [12.8](/filings/0000876427-26-000012.md) | [18.6](/filings/0000876427-26-000004.md) | [(5.2) d](/filings/0000876427-26-000007.md) | [3.7](/filings/0000876427-26-000010.md) | [2.6](/filings/0000876427-26-000012.md) |
| Income tax | $m | [4.2](/filings/0001562762-25-000015.md) | [2.0 d](/filings/0000876427-26-000007.md) | [2.3](/filings/0001562762-25-000184.md) | [2.5](/filings/0000876427-25-000005.md) | [1.2](/filings/0000876427-26-000004.md) | [(6.8) d](/filings/0000876427-26-000007.md) | [(2.7)](/filings/0000876427-26-000010.md) | [2.8](/filings/0000876427-26-000012.md) | [3.4](/filings/0000876427-26-000004.md) | [(2.6) d](/filings/0000876427-26-000007.md) | [0.2](/filings/0000876427-26-000010.md) | [(0.3)](/filings/0000876427-26-000012.md) |
| Net income | $m | [12.2](/filings/0001562762-25-000015.md) | [3.7 d](/filings/0000876427-26-000007.md) | [5.9](/filings/0001562762-25-000184.md) | [5.6](/filings/0000876427-25-000005.md) | [4.6](/filings/0000876427-26-000004.md) | [(21.3) d](/filings/0000876427-26-000007.md) | [(8.1)](/filings/0000876427-26-000010.md) | [5.7](/filings/0000876427-26-000012.md) | [11.1](/filings/0000876427-26-000004.md) | [(6.6) d](/filings/0000876427-26-000007.md) | [(2.1)](/filings/0000876427-26-000010.md) | [(1.6)](/filings/0000876427-26-000012.md) |
| Diluted EPS | $ per share | [0.38](/filings/0001562762-25-000015.md) | not reported | [0.19](/filings/0001562762-25-000184.md) | [0.18](/filings/0000876427-25-000005.md) | [0.15](/filings/0000876427-26-000004.md) | not reported | [(0.28)](/filings/0000876427-26-000010.md) | [0.18](/filings/0000876427-26-000012.md) | [0.35](/filings/0000876427-26-000004.md) | not reported | [(0.08)](/filings/0000876427-26-000010.md) | [(0.05)](/filings/0000876427-26-000012.md) |
| Basic EPS | $ per share | [0.38](/filings/0001562762-25-000015.md) | not reported | [0.19](/filings/0001562762-25-000184.md) | [0.18](/filings/0000876427-25-000005.md) | [0.15](/filings/0000876427-26-000004.md) | not reported | [(0.28)](/filings/0000876427-26-000010.md) | [0.18](/filings/0000876427-26-000012.md) | [0.36](/filings/0000876427-26-000004.md) | not reported | [(0.08)](/filings/0000876427-26-000010.md) | [(0.05)](/filings/0000876427-26-000012.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-12-23) | FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) | Q2 FY2027 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [23.8](/filings/0001562762-24-000011.md) | [6.6](/filings/0001562762-25-000146.md) | [18.7](/filings/0001562762-24-000189.md) | [20.9](/filings/0001562762-24-000244.md) | [10.2](/filings/0001562762-25-000015.md) | [20.8](/filings/0000876427-26-000007.md) | [7.8](/filings/0001562762-25-000184.md) | [10.5](/filings/0000876427-25-000005.md) | [4.9](/filings/0000876427-26-000004.md) | [14.6](/filings/0000876427-26-000012.md) | [9.5](/filings/0000876427-26-000010.md) | [15.0](/filings/0000876427-26-000012.md) |
| Current assets | $m | [272](/filings/0001562762-24-000011.md) | [253](/filings/0001562762-25-000146.md) | [278](/filings/0001562762-24-000189.md) | [267](/filings/0001562762-24-000244.md) | [274](/filings/0001562762-25-000015.md) | [277](/filings/0000876427-26-000007.md) | [255](/filings/0001562762-25-000184.md) | [243](/filings/0000876427-25-000005.md) | [229](/filings/0000876427-26-000004.md) | [237](/filings/0000876427-26-000012.md) | [232](/filings/0000876427-26-000010.md) | [234](/filings/0000876427-26-000012.md) |
| Total assets | $m | [1,733](/filings/0001562762-24-000011.md) | [1,693](/filings/0001562762-25-000146.md) | [1,712](/filings/0001562762-24-000189.md) | [1,681](/filings/0001562762-24-000244.md) | [1,670](/filings/0001562762-25-000015.md) | [1,642](/filings/0000876427-26-000007.md) | [1,605](/filings/0001562762-25-000184.md) | [1,584](/filings/0000876427-25-000005.md) | [1,570](/filings/0000876427-26-000004.md) | [1,568](/filings/0000876427-26-000012.md) | [1,557](/filings/0000876427-26-000010.md) | [1,545](/filings/0000876427-26-000012.md) |
| Current liabilities | $m | [487](/filings/0001562762-24-000011.md) | [455](/filings/0001562762-25-000146.md) | [469](/filings/0001562762-24-000189.md) | [502](/filings/0001562762-24-000244.md) | [508](/filings/0001562762-25-000015.md) | [524](/filings/0000876427-26-000007.md) | [506](/filings/0001562762-25-000184.md) | [511](/filings/0000876427-25-000005.md) | [503](/filings/0000876427-26-000004.md) | [518](/filings/0000876427-26-000012.md) | [473](/filings/0000876427-26-000010.md) | [491](/filings/0000876427-26-000012.md) |
| Total liabilities | $m | [1,073](/filings/0001562762-24-000011.md) | [1,036](/filings/0001562762-25-000146.md) | [1,058](/filings/0001562762-24-000189.md) | [1,029](/filings/0001562762-24-000244.md) | [1,021](/filings/0001562762-25-000015.md) | [1,021](/filings/0000876427-26-000007.md) | [1,000](/filings/0001562762-25-000184.md) | [982](/filings/0000876427-25-000005.md) | [965](/filings/0000876427-26-000004.md) | [977](/filings/0000876427-26-000012.md) | [974](/filings/0000876427-26-000010.md) | [971](/filings/0000876427-26-000012.md) |
| Long-term debt | $m | [94.0](/filings/0001562762-24-000011.md) | [102](/filings/0001562762-25-000146.md) | [112](/filings/0001562762-24-000189.md) | [62.0](/filings/0001562762-24-000244.md) | [59.3](/filings/0001562762-25-000015.md) | [61.3](/filings/0000876427-26-000007.md) | [71.5](/filings/0001562762-25-000184.md) | [60.0](/filings/0000876427-25-000005.md) | [45.0](/filings/0000876427-26-000004.md) | [60.0](/filings/0000876427-26-000012.md) | [108](/filings/0000876427-26-000010.md) | [100](/filings/0000876427-26-000012.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [660](/filings/0001562762-25-000015.md) | [657](/filings/0000876427-26-000007.md) | [654](/filings/0000876427-25-000005.md) | [652](/filings/0000876427-26-000004.md) | [649](/filings/0000876427-26-000004.md) | [621](/filings/0000876427-26-000012.md) | [605](/filings/0000876427-26-000012.md) | [602](/filings/0000876427-26-000012.md) | [605](/filings/0000876427-26-000004.md) | [591](/filings/0000876427-26-000012.md) | [583](/filings/0000876427-26-000012.md) | [574](/filings/0000876427-26-000012.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-12-23) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) | Q2 FY2027 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [32.2 d](/filings/0001562762-25-000015.md) | [(5.3) d](/filings/0000876427-26-000007.md) | [25.6](/filings/0001562762-25-000184.md) | [62.6 d](/filings/0000876427-25-000005.md) | [14.8 d](/filings/0000876427-26-000004.md) | [28.9 d](/filings/0000876427-26-000007.md) | [(1.9)](/filings/0000876427-26-000010.md) | [32.3 d](/filings/0000876427-26-000012.md) | [17.8 d](/filings/0000876427-26-000004.md) | [22.2 d](/filings/0000876427-26-000007.md) | [(30.4)](/filings/0000876427-26-000010.md) | [34.6 d](/filings/0000876427-26-000012.md) |
| Capital expenditure | $m | [3.2 d](/filings/0001562762-25-000015.md) | [6.6 d](/filings/0000876427-26-000007.md) | [8.9](/filings/0001562762-25-000184.md) | [4.9 d](/filings/0000876427-25-000005.md) | [6.9 d](/filings/0000876427-26-000004.md) | [5.7 d](/filings/0000876427-26-000007.md) | [7.4](/filings/0000876427-26-000010.md) | [5.7 d](/filings/0000876427-26-000012.md) | [8.7 d](/filings/0000876427-26-000004.md) | [9.8 d](/filings/0000876427-26-000007.md) | [7.5](/filings/0000876427-26-000010.md) | [5.8 d](/filings/0000876427-26-000012.md) |
| Dividends paid | $m | [8.9 d](/filings/0001562762-25-000015.md) | [8.7 d](/filings/0000876427-26-000007.md) | [8.7](/filings/0001562762-25-000184.md) | [8.7 d](/filings/0000876427-25-000005.md) | [8.4 d](/filings/0000876427-26-000004.md) | [9.1 d](/filings/0000876427-26-000007.md) | [8.7](/filings/0000876427-26-000010.md) | [8.7 d](/filings/0000876427-26-000012.md) | [8.7 d](/filings/0000876427-26-000004.md) | [8.7 d](/filings/0000876427-26-000007.md) | [8.7](/filings/0000876427-26-000010.md) | [8.8 d](/filings/0000876427-26-000012.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0000876427-26-000007.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-12-24) | Q1 FY2024 (2023-06-24) | Q2 FY2024 (2023-09-23) | Q3 FY2024 (2023-12-23) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q1 FY2027 (2026-06-27) | Q2 FY2027 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.0](/filings/0001562762-24-000011.md) | [32.0](/filings/0001562762-24-000189.md) | [32.3](/filings/0001562762-24-000244.md) | [32.2](/filings/0001562762-25-000015.md) | [31.2](/filings/0001562762-25-000184.md) | [31.2](/filings/0000876427-25-000005.md) | [31.3](/filings/0000876427-26-000004.md) | [30.0](/filings/0000876427-26-000010.md) | [31.4](/filings/0000876427-26-000012.md) | [31.4](/filings/0000876427-26-000004.md) | [30.1](/filings/0000876427-26-000010.md) | [31.3](/filings/0000876427-26-000012.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 31,326,927 at 2026-10-16, from the cover of the [10-Q filed 2026-10-29](/filings/0000876427-26-000012.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 08:05 ET. No prices; not investment advice.